Schwetz B, Gaylor D
U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, Arkansas 72079-9502, USA.
Environ Health Perspect. 1998 Apr;106 Suppl 2(Suppl 2):467-71. doi: 10.1289/ehp.98106467.
Acceptance of new tests that are alternatives to currently used toxicology tests is a topic of considerable importance in the field of toxicology. Carcinogenicity testing today normally includes 2-year studies in rats and mice of both sexes, following widely accepted procedures for husbandry; selection of dose levels; pathology and toxicity observations; and statistical interpretation of tumor data. These studies are usually preceded by tests for genetic toxicity and subchronic toxicity studies to select dose levels for the 2-year studies. Although these data are used for quantitative risk assessment, the mechanistic basis for effects is usually unknown. The series of studies is very expensive and requires 5 years or more to conduct. Alternative approaches are being developed that would provide more mechanistic information and hopefully would permit decisions to be made about carcinogenic potential without the need to conduct 2-year studies in rats and mice of both sexes. Decisions could be based on a profile of data rather than on the result of one test. Procedures for regulatory acceptance of new approaches for carcinogenicity testing are critical to future progress.
接受可替代当前所用毒理学测试的新测试,是毒理学领域一个相当重要的话题。如今的致癌性测试通常包括按照广泛接受的饲养程序,对雌雄大鼠和小鼠进行为期两年的研究;选择剂量水平;进行病理学和毒性观察;以及对肿瘤数据进行统计学解读。这些研究通常之前会进行遗传毒性测试和亚慢性毒性研究,以选择两年研究的剂量水平。尽管这些数据用于定量风险评估,但效应的作用机制通常未知。这一系列研究成本非常高,需要5年或更长时间来开展。正在开发的替代方法将提供更多的作用机制信息,并有望在无需对雌雄大鼠和小鼠进行为期两年研究的情况下,就能对致癌潜力做出决策。决策可以基于一系列数据,而不是一项测试的结果。新的致癌性测试方法获得监管认可的程序对未来的进展至关重要。